(S)-2-(3-Amino-4-((S)-2-amino-4-(4-hydroxyphenyl)-butanamido)benzamido)-3-(1H-indol-3-yl)propanoic Acid

ID: ALA3416720

Chembl Id: CHEMBL3416720

PubChem CID: 118734287

Max Phase: Preclinical

Molecular Formula: C28H29N5O5

Molecular Weight: 515.57

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1cc(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)ccc1NC(=O)[C@@H](N)CCc1ccc(O)cc1

Standard InChI:  InChI=1S/C28H29N5O5/c29-21(11-7-16-5-9-19(34)10-6-16)27(36)32-24-12-8-17(13-22(24)30)26(35)33-25(28(37)38)14-18-15-31-23-4-2-1-3-20(18)23/h1-6,8-10,12-13,15,21,25,31,34H,7,11,14,29-30H2,(H,32,36)(H,33,35)(H,37,38)/t21-,25-/m0/s1

Standard InChI Key:  QFIZLFVZFOTXHE-OFVILXPXSA-N

Alternative Forms

  1. Parent:

    ALA3416720

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNPEP Tchem Cystinyl aminopeptidase (313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 515.57Molecular Weight (Monoisotopic): 515.2169AlogP: 2.78#Rotatable Bonds: 10
Polar Surface Area: 183.56Molecular Species: ACIDHBA: 6HBD: 7
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 9#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.82CX Basic pKa: 8.24CX LogP: 0.44CX LogD: 0.38
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.16Np Likeness Score: -0.17

References

1. Papakyriakou A, Zervoudi E, Tsoukalidou S, Mauvais FX, Sfyroera G, Mastellos DC, van Endert P, Theodorakis EA, Vourloumis D, Stratikos E..  (2015)  3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties.,  58  (3): [PMID:25635706] [10.1021/jm501867s]

Source